Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • ILCA 2023 | When HIV Infection Coexists with HCC: Patient Clinical Features, Treatment Status, and Outcomes

     After the HIV virus enters the human body, it first destroys the immune system, leading to a rapid decline in immunity. Consequently, the body becomes more susceptible to various infections and complications, the most common of which are infections in different systems and malignant tumors. As the life expectancy of people living with HIV (PLWH)…

    2024.01.31
  • Dr. Qiang Gao: The Complexity and Diversity of Tumor-Immune Interactions in Intrahepatic Cholangiocarcinoma

     Intrahepatic cholangiocarcinoma (ICC) refers to adenocarcinoma originating from the epithelium of secondary bile ducts and their branches, accounting for 10%-15% of primary malignant tumors in the liver. In recent years, the incidence of ICC has been rising significantly, garnering increasing clinical attention. While ICC and hepatocellular carcinoma (HCC) both belong to primary liver cancers, they…

    2024.01.31
  • ESMO China Voice | Professor Long Shichun: Targeted Immunotherapy Offers Hope for Curative Resection and Long-Term Survival in Unresectable Liver Cancer

    Due to the insidious nature of liver cancer, most patients are diagnosed in the advanced stages, losing the opportunity for curative surgery and facing a poor prognosis. In recent years,…

    2024.01.31
  • ESMO 2023: Advancements in Oncology, Honoring Excellence, and the Global Impact

    The European Society for Medical Oncology (ESMO) 2023 Congress held in Madrid was a momentous event that brought together oncology professionals and researchers from across the globe. This comprehensive article…

    2024.01.31
  • Insights from ASCO GU: An Exclusive Interview with UBC’s Marie-Pier St-Laurent | Oncology Frontier

    Welcome to a special feature by Oncology Frontier, where we bridge the gap between continents in the realm of medical innovation. Today, we’re honored to host Marie-Pier St-Laurent from the University of British Columbia. As part of our exclusive Specialist Interview series, Marie-Pier will be sharing valuable insights from her recent abstract presented at ASCO…

    2024.01.31
  • The U.S. Experience in HCV Screening, Linkage, and Treatment

    2024.01.31
  • Pinnacle Conversation | Advancements in the Diagnosis and Treatment of Metabolism-Related Fatty Liver Disease: Discussing New Developments, Sharing Experiences from Singapore and the United States, and Addressing Global Progress

    2024.01.31
  • Interview with AASLD President: A Resurgence of Vitality in the Field of Liver Disease, Highlights Galore at 2023 Annual Meeting

    2024.01.31
«previous next»
Recent Posts
  • 2026 Pujiang Urological Oncology Academic Conference丨Chunguang Ma: Immunotherapy Opens a New Era in Adjuvant Treatment for Urothelial Carcinoma—From a Shift in Perioperative Concepts to Precision Whole-Course Management
  • Professor Yongmei Yin: Advancing Precision Oncology from Concept to Clinical Practice — Key Insights from the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs
  • 2026 Northern Breast Cancer Salon · Getting to the Bottom of It丨Professors Wenyan Chen and Ning Xie: Treatment Options for HER2-Positive Metastatic Breast Cancer After Failure of H-Based Therapy
  • 2026 Northern Breast Cancer Salon · Time & Memory丨Professor Guohong Song: Breaking New Ground and Advancing Further — The Evolution of HER2-Positive Breast Cancer Treatment and the New Treatment Landscape in the ADC Era
  • 2026 Northern Breast Cancer Salon · Time & Memory | Professor Yongmei Yin: Seeing the Subtle to Foresee the Far — The Evolution of Precision Diagnosis and Treatment in Breast Cancer from Molecular Subtyping to Gene-Guided Therapy
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top